1. Home
  2. CVM vs PDSB Comparison

CVM vs PDSB Comparison

Compare CVM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$5.55

Market Cap

53.1M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.08

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVM
PDSB
Founded
1983
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
49.5M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
CVM
PDSB
Price
$5.55
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
70.4K
494.0K
Earning Date
02-13-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$0.70
52 Week High
$20.41
$2.20

Technical Indicators

Market Signals
Indicator
CVM
PDSB
Relative Strength Index (RSI) 46.10 66.78
Support Level $5.01 $0.76
Resistance Level $6.37 $0.93
Average True Range (ATR) 0.55 0.07
MACD 0.14 0.02
Stochastic Oscillator 63.41 82.01

Price Performance

Historical Comparison
CVM
PDSB

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: